{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-144290","form_type":"8-K","ticker":"ILMN","cik":"0001110803","company_name":"ILLUMINA, INC.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.554114+00:00","generated_at":"2026-05-18T23:22:48.237369+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Illumina to acquire SomaLogic for $350M cash plus up to $75M milestones","bullets":["Illumina will acquire SomaLogic's aptamer-based proteomics business from Standard BioTools for $350M cash at closing, plus up to $75M in milestones and royalties.","Transaction includes SomaLogic's SomaScan assay, CLIA/CAP lab in Boulder, CO, and ~250 employees; builds on co-development since 2021.","Illumina expects the business to become profitable on a non-GAAP basis in 2027, with operating margins in line with Illumina by 2028.","Closing expected in first half of 2026, subject to HSR and other customary conditions; termination fee of $14.5M under certain circumstances.","Illumina Protein Prep (SomaScan on NGS) already has ~40 early-access customers, full availability in Q3 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-144290","json":"https://secwatch.observer/filing/0001193125-25-144290.json","markdown":"https://secwatch.observer/filing/0001193125-25-144290.md","text":"https://secwatch.observer/filing/0001193125-25-144290.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1110803/000119312525144290/0001193125-25-144290-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1110803/000119312525144290/d66921d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T23:22:48.237369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}